TGen-led study seeks to understand why some HIV-positive men are more infectious than others
Study showed significant links between bacteria, viruses and the immune system in the semen during HIV infection
FLAGSTAFF, Ariz. - July 24, 2014 - A new study led by
the Translational Genomics Research Institute (TGen) provides insights into
the interplay among bacteria, viruses and the immune
system during HIV infection.
Currently, doctors measure HIV-positive men's infectivity - their potential to infect others - based on their blood viral
load. However, some men produce large amounts of virus in their semen despite having low levels in their blood. Researchers call
this "compartmentalization," where different levels of the virus can be found in different parts of the body; in this
case, in the semen, versus the blood.
Because of the importance of semen in HIV transmission - in both homosexual and heterosexual populations - researchers who
conducted the study published today in the journal PLOS Pathogens sought to understand how HIV could be localized, or compartmentalized,
in the semen.
Significantly, the study revealed a link between higher levels of HIV and higher levels of both bacteria and cytokines,
biochemicals that can be described as the immune system's alarm bells.
"Our study is trying to tackle an important problem in HIV research," said Dr. Lance Price, Director of TGen's
Center for Microbiomics and Human Health, and one of the study's senior authors. "We found that HIV infection affects the
relationship between semen bacteria and immune system, and both are linked to semen HIV levels."
These findings could point to new ways to control the spread of HIV, said Dr. Price. "Our data suggest that semen bacteria
may play a role in localized inflammation and HIV viral load in the semen, which is an important target for reducing HIV
While HIV can be found in many body fluids (semen, vaginal secretions, blood and breast milk), it is most commonly
transmitted via semen in both homosexual and heterosexual sex.
Homosexual men were the focus of this study because they continue to be the population most at risk for HIV in North America.
The study included 27 homosexual men infected with HIV, and 22 homosexual men who were uninfected.
The 27 infected individuals were examined before treatment, and at both one-month and six-month intervals following treatment
with anti-retroviral therapy (ART). Samples from the 22 uninfected participants in the study served as controls.
"By comparing the semen bacteria in both uninfected and infected men, we found that HIV can cause an imbalance in the
semen microbiome," said Dr. Cindy Liu, the study's lead author, a clinical pathology resident at the Johns Hopkins School of
Medicine, and an adjunct professor at TGen at the time of the study. "This imbalance can be corrected by HIV treatment.
This suggests that there are complex host-microbe interactions in the semen."
"We have taken the first step to show that bacteria, HIV, and immune response in the semen may be
connected," said Dr. Rupert Kaul, an immunologist from the University of Toronto, and another senior author of
the study. "What we need to better understand next is the precise relationship between these three
factors - whether the bacterial imbalance is the trigger or the result of the localized immune response."
The authors of the study, The Semen Microbiome and Its Relationship with Local Immunology and Viral Load in HIV Infection,
are particularly excited about what this research may mean for another important patient population.
"Even though we have focused on men whose semen viral load can be controlled with HIV treatment in this study," said
Dr. Kaul, "we need to study men who continue to have high HIV levels in their semen despite being on treatment. This will be important
to improving how we treat patients and control the spread of HIV."
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking
research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting
edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to
unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the
scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through
efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.
TGen Senior Science Writer
"Reproduced with permission - Translational Genomics Research Institute (TGen)"
Translational Genomics Research Institute (TGen)
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS: